These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17085516)

  • 21. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.
    Stebbing J; Gazzard B; Mandalia S; Teague A; Waterston A; Marvin V; Nelson M; Bower M
    J Clin Oncol; 2004 Jun; 22(11):2177-83. PubMed ID: 15169806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
    Levine AM
    Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
    Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H
    Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raltegravir-based HAART regimen in a patient with large B-cell lymphoma.
    Fulco PP; Hynicka L; Rackley D
    Ann Pharmacother; 2010 Feb; 44(2):377-82. PubMed ID: 20040700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update in HIV lymphoma.
    Noy A
    Curr Opin Oncol; 2006 Sep; 18(5):449-55. PubMed ID: 16894292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.
    Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Flores A; Millá F; Feliu E
    Br J Haematol; 2001 Mar; 112(4):909-15. PubMed ID: 11298585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART): an African perspective.
    Sissolak G; Abayomi EA; Jacobs P
    Transfus Apher Sci; 2007 Aug; 37(1):63-70. PubMed ID: 17931978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
    Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
    Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
    Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
    HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the management of HIV-related non-Hodgkin lymphoma.
    Behler CM; Kaplan LD
    Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
    Boulanger E; Brière J; Gaulard P; Droz D; Oksenhendler E
    Am J Hematol; 2003 Jan; 72(1):70-1. PubMed ID: 12508272
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
    Castillo J; Pantanowitz L; Dezube BJ
    Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.